Search Results
Philip H. Oettinger
Partner
Philip focuses primarily on the representation of medical device, biotechnology, pharmaceutical, diagnostic, and digital health companies in corporate governance, IPO, M&A, public company reporting, and private equity and debt financing matters.
Elton Satusky
Partner
Elton specializes in public and private corporate finance and corporate law and governance. He also has considerable M&A and venture capital experience.
Scott K. Murano
Partner
Scott advises clients in a broad range of corporate transactions and related matters.
Martin J. Waters
Partner
Marty represents innovative life sciences and technology clients in corporate transactions and governance matters.
Eric Y. Hsu
Partner
Eric Hsu is a corporate and securities partner in the life sciences practice at Wilson Sonsini Goodrich & Rosati. He represents emerging growth companies in areas such as medical devices, digital health, and biotechnology. Eric advises public and private companies on general corporate matters, mergers and acquisitions, initial public offerings, public company reporting, strategic partnerships, venture capital financings, and private equity and debt financings.
Brian Appel
Partner
Brian Appel is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he practices corporate and securities law. He advises companies on general corporate matters, including formation and operation, corporate governance, debt and equity financings, mergers and acquisitions, and securities-related matters. He has assisted early-stage companies in numerous capital-raising transactions, including venture capital financings.
Zachary B. Myers
Partner
Zach advises entrepreneurs, innovative companies and other clients on corporate matters.
J. Matthew (Matt) Lyons
Partner
J. Matthew (Matt) Lyons is a corporate partner in the Austin office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on the representation of companies and their investors in the emerging companies ecosystem. For the past 25 years, he has been a leading attorney in the Texas market, advising public and private companies, venture and private equity funds, and entrepreneurs on new entity formation, venture financings, public and private offerings, mergers, acquisitions and divestitures, and issues related to corporate governance and executive compensation. Matt’s clients include companies in the technology, life sciences, healthcare, retail and CPG, and media and communications industries.
Alex Key
Partner
Alex focuses on representing clients in the biotechnology, pharmaceutical, medical device, diagnostic, and digital health industries.
Eva F. Yin
Partner
Eva Yin, Ph.D., M.P.H., is a partner in Wilson Sonsini Goodrich & Rosati’s FDA regulatory, healthcare, and consumer products practice. Her practice includes conducting FDA and healthcare regulatory due diligence for corporate transactions; providing legal counsel to manufacturers regarding FDA approval/clearance for various products—including medical devices, mobile apps, and drugs, FDA compliance, regulation of promotional materials and labeling, and manufacturer compliance under federal and state healthcare laws, e.g., the federal Anti-Kickback Statute (AKS), False Claims Act (FCA), Sunshine Act, state licensing laws, corporate practice of medicine, etc.; reviewing contracts and compliance policies for manufacturers; and providing legal analysis and risk assessment of business models and fee arrangements involving patient assistance programs, healthcare professionals, or hospitals/clinics under federal and state healthcare laws and regulations.
Aaron D. Hendelman
Partner
Aaron heads the firm's trademark and advertising practice, focusing on the areas of trademark, advertising, unfair competition, copyright, retail, rights of publicity, social media, and consumer law.
Alyssa M. Worsham
Partner
Alyssa Worsham is a member of the firm’s trademark and advertising team, which has been recognized in Chambers and Partners’ USA and Global guides, as well as World Trademark Review’s WTR 1000. She focuses on global strategic advice, litigation strategy, and transactional guidance for clients’ trademarks, branding, and advertising in marketplaces where commercial and geographic lines are increasingly blurring. She helps clients assess the risk in selecting new business and product names, and works with them to build, exploit, and protect these names creatively and strategically. Alyssa advises on trademark disputes, domain name disputes, contests and sweepstakes, advertising review, right of publicity, social media issues, Telephone Consumer Protection Act (TCPA) compliance (i.e., the rules surrounding marketing texts and calls), FTC compliance and investigations, copyright, IP diligence, and associated commercial contracts. She works with software companies, biotech start-ups, cosmetics companies, fashion companies, life sciences and digital health companies, agro-tech companies, consumer products, non-profits, and game developers, among others. She advises founders, CEOs, GCs, IP specialists, and chief marketing officers on the critical issues surrounding brand creation, protection, and strategy.
Christine K. Au-Yeung
Partner
Christine Au-Yeung is a partner in the San Francisco and Palo Alto offices of Wilson Sonsini Goodrich & Rosati, where she focuses on trademark, copyright, and advertising law. She counsels clients on all aspects of brand protection in the U.S. and throughout the world, including clearance and selection of trademarks, prosecution of trademark applications, licensing, and the resolution of trademark infringement and domain name disputes. She also advises clients on advertising issues, including TCPA compliance related to marketing calls and texts, as well as strategies on promotions such as sweepstakes and contests.
Ali R. Alemozafar
Partner
Ali counsels clients on patent strategy, prosecution, and diligence for financings, M&A, and IPOs.
Mark W. Bellomy
Partner
Mark Bellomy is a partner in Wilson Sonsini Goodrich & Rosati’s Boston office, where he is a member of the technology transactions practice. Mark advises numerous domestic and international public and private biopharmaceutical, medtech, digital health, medical device, and life sciences companies on all of the transactions related to the discovery, development, supply, and commercialization of their products, technologies, and services. He counsels clients with respect to structuring and negotiating a wide range of arrangements designed to maximize the value of their businesses.
Miranda Biven
Partner
Miranda advises life sciences clients in partnering and licensing arrangements, M&A, and other transactions.
Nellie J. Brutocao
Partner
Nellie Brutocao is a partner in the technology transactions practice at Wilson Sonsini Goodrich & Rosati. Her practice focuses on the life sciences industry, representing public and private companies in intellectual property and commercial transactions, including strategic alliances, research and development collaborations, technology licenses and acquisitions, supply, distribution and manufacturing agreements, sponsored research agreements, clinical trials arrangements, material transfer agreements, and co-promotion arrangements. She has also represented life sciences companies in complex commercial and patent disputes, including Hatch-Waxman litigation.
Matthew P. Dubofsky
Partner
Matthew P. Dubofsky is a partner in the Boulder office of Wilson Sonsini Goodrich & Rosati, where he focuses on the corporate and transactional representation of technology and healthcare companies. He also advises issuers and underwriters on capital markets transactions, and represents both buy- and sell-side clients in M&A transactions. In addition, he represents venture capital funds and companies in equity financing transactions. Matt’s clients range from early-stage start-ups through pre-IPO, in addition to public companies, and he has deep experience across a variety of industries, including information technology, cybersecurity, software, retail, healthcare, biotechnology, and medical devices.
U.P. Peter Eng
Partner
Specializes in strategic patent and innovation counseling for technology start-ups.
Jennifer Fang
Partner
Jennifer helps innovative start-ups grow into successful enterprises by providing counsel to the founders, management teams, and boards.
Brent Fassett
Partner
Brent Fassett is a corporate partner in the Boulder office of Wilson Sonsini Goodrich & Rosati, where he represents emerging growth companies and the investors that support them, focusing on the life sciences and medical technology industries. He specializes in venture capital financings, public and private merger and acquisition transactions, IPOs, licensing and commercial agreements, employee compensation plans, public company reporting and disclosure issues, and securities law compliance.
Mark R. Fitzgerald
Partner
Mark is a veteran attorney who advises technology and life sciences companies on corporate law and transactional matters.
Seth Flaum
Partner
Seth Flaum is a partner in the New York office of Wilson Sonsini Goodrich & Rosati, where he is a member of the technology transactions practice. With more than 25 years of broad transactional experience, he represents life sciences companies in a wide range of strategic transactions and corporate matters.
Salil Gandhi
Partner
Salil Gandhi is a partner in the New York office of Wilson Sonsini Goodrich & Rosati and a co-leader of the firm’s emerging companies practice. Salil focuses on corporate and securities law and specializes in the representation of emerging growth companies throughout their lifecycles, particularly in the life sciences and technology sectors. He also counsels venture capital funds and other private equity funds on structuring and executing investment transactions ranging from angel to control investments, as well as portfolio dispositions.
Farah B. Gerdes
Partner
Farah focuses on the representation of pharmaceutical, biotechnology, medical device, and diagnostic companies in complex collaboration and partnering transactions.
Daniel Glazer
Partner
Daniel counsels UK and European tech and life sciences companies on U.S. expansion and fundraising.
Andrew D. Hoffman
Partner
Andrew’s practice focuses on corporate and securities work for companies at all stages of growth, as well as for financial institutions, venture capital firms, and other investors.
Steffen N. Johnson
Partner
Steffen Johnson is an experienced appellate practitioner who co-chairs the firm's national Supreme Court and Appellate practice.